TIDMSBS

RNS Number : 6798E

Source BioScience PLC

05 November 2015

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 
 
 
 1. Identity of the issuer or the        Source BioScience plc 
  underlying issuer of existing shares 
  to which voting rights are attached: 
  (ii) 
--------------------------------------  ---------------------- 
 
 
 2 Reason for the notification (please tick the appropriate box 
  or boxes): 
------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                             ΓΌ 
-----------------------------------------------------------------  ------------ 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already 
  issued to which voting rights are attached 
-----------------------------------------------------------------  ------------ 
 An acquisition or disposal of instruments with similar 
  economic effect to qualifying financial instruments 
-----------------------------------------------------------------  ------------ 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------  ------------ 
 Other (please 
  specify): 
-----------------  ----------------------------------------------  ------------ 
 
 
 
 3. Full name of person(s) subject     CHARIOT FUND - SPARTAN FUND LTD. 
  to the notification obligation:                 SAC CLASS B 
  (iii) 
------------------------------------  --------------------------------- 
 4. Full name of shareholder(s)        CHARIOT FUND - SPARTAN FUND LTD. 
  (if different from 3.): (iv)                    SAC CLASS B 
------------------------------------  --------------------------------- 
 5. Date of the transaction and                21 October 2015 
  date on which the threshold is 
  crossed or reached: (v) 
------------------------------------  --------------------------------- 
 6. Date on which issuer notified:             4 November 2015 
------------------------------------  --------------------------------- 
 7. Threshold(s) that is/are crossed               Over 3% 
  or 
  reached: (vi, vii) 
------------------------------------  --------------------------------- 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous        Resulting situation after the triggering 
  of              to the triggering         transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ------------------------  ------------------------------------------------------- 
                 Number       Number       Number       Number of voting        % of voting 
                  of           of           of shares    rights                  rights (x) 
                  Shares       Voting 
                               Rights 
--------------  -----------  -----------  -----------  ----------------------  ------------------ 
                                           Direct       Direct       Indirect   Direct   Indirect 
                                                         (xi)         (xii) 
--------------  -----------  -----------  -----------  -----------  ---------  -------  --------- 
 GB0009739649    16,021,429   16,021,429   17,491,429   17,491,429     N/A      5.01%    N/A 
--------------  -----------  -----------  -----------  -----------  ---------  -------  --------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------- 
 Type of financial   Expiration     Exercise/       Number of voting         % of voting 
  instrument          date (xiii)    Conversion      rights that              rights 
                                     Period (xiv)    may be 
                                                     acquired if 
                                                     the 
                                                     instrument is 
                                                     exercised/ converted. 
------------------  -------------  --------------  -----------------------  ------------ 
  N/A 
------------------  -------------  --------------  -----------------------  ------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying 
  Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
 N/A                                                                            Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
  17,491,429                5.01% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
--------------------------------------------------------------------------- 
 
   N/A 
--------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
------------------------------------------- 
 10. Name of the proxy holder:          N/A 
------------------------------------  ----- 
 11. Number of voting rights proxy      N/A 
  holder will cease to hold: 
------------------------------------  ----- 
 12. Date on which proxy holder will    N/A 
  cease to hold voting rights: 
------------------------------------  ----- 
 
 
 13. Additional information:      N/A 
------------------------------  ----- 
 14. Contact name:                N/A 
------------------------------  ----- 
 15. Contact telephone number:    N/A 
------------------------------  ----- 
 
 
 Note: Annex should only be submitted to the FCA not the issuer 
 Annex: Notification of major interests in share 
 
 A: Identity of the persons or legal entity subject to the notification 
  obligation 
-------------------------------------------------------------------------------- 
 Full name                             CHARIOT FUND, SPARTAN FUND LTD. 
  (including legal form of legal        SAC CLASS B 
  entities) 
------------------------------------  ------------------------------------------ 
 Contact address                       Equity Trust House, Caves Village 
  (registered office for legal          West Bay Street Nassau, Bahamas 
  entities)                             N-10697 
------------------------------------  ------------------------------------------ 
 Phone number & email                  +1 (242) 676-8188 
                                        mdean@equitybahamas.com 
------------------------------------  ------------------------------------------ 
 Other useful information              Michael Dean, Vice President Investment 
  (at least legal representative        Funds Services 
  for legal persons) 
------------------------------------  ------------------------------------------ 
 
 B: Identity of the notifier, if applicable 
-------------------------------------------------------------------------------- 
 Full name 
-------------------------------------------  ----------------------------------- 
 Contact address 
-------------------------------------------  ----------------------------------- 
 Phone number & email 
-------------------------------------------  ----------------------------------- 
 Other useful information 
  (e.g. functional relationship with 
  the person or legal entity subject 
  to the notification obligation) 
-------------------------------------------  ----------------------------------- 
 
 C: Additional information 
-------------------------------------------------------------------------------- 
 
 For notes on how to complete form TR-1 please see the FCA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUGGWPGUPAGUA

(END) Dow Jones Newswires

November 05, 2015 05:27 ET (10:27 GMT)

Medical Solutions (LSE:MLS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Medical Solutions Charts.
Medical Solutions (LSE:MLS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Medical Solutions Charts.